Showing results (91-100 of 100) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
Scandinavian Journal of Immunology|September 1, 1981
Human blood monocytes: characterization of negatively selected human monocytes and their suspension cell culture derivativesH C Stevenson, P Katz, D G Wright, et al.
Neurology|September 26, 2008
Atrial fibrillation detected by mobile cardiac outpatient telemetry in cryptogenic TIA or strokeA H Tayal, M Tian, K M Kelly, et al.
Transfusion|March 3, 1998
Mobilized CD34+ cells selected as autografts in patients with primary light-chain amyloidosis: rationale and applicationR L Comenzo, D Michelle, M LeBlanc, et al.
Experimental Hematology|May 1, 1992
Effects of anti-CD33 blocked ricin immunotoxin on the capacity of CD34+ human marrow cells to establish in vitro hematopoiesis in long-term marrow culturesV F La Russa, J D Griffin, S W Kessler, et al.
Bone Marrow Transplantation|June 26, 2007
Tandem cycles of high-dose melphalan and autologous stem cell transplantation increases the response rate in AL amyloidosisV Sanchorawala, D G Wright, K Quillen, et al.
Bone Marrow Transplantation|January 23, 2002
Immunologic recovery after autologous blood stem cell transplantation in patients with AL-amyloidosisG Akpek, G Lenz, S M Lee, et al.
Thrombosis Research|January 3, 2015
Safety of venous thromboembolism prophylaxis with fondaparinux in ischemic strokeC T Hackett, R S Ramanathan, K Malhotra, et al.
Blood|October 1, 1996
Dose-intensive melphalan with blood stem cell support for the treatment of AL amyloidosis: one-year follow-up in five patientsR L Comenzo, E Vosburgh, R W Simms, et al.
Bone Marrow Transplantation|December 17, 2003
High-dose intravenous melphalan and autologous stem cell transplantation as initial therapy or following two cycles of oral chemotherapy for the treatment of AL amyloidosis: results of a prospective randomized trialV Sanchorawala, D G Wright, D C Seldin, et al.
Blood|June 20, 1998
Dose-intensive melphalan with blood stem-cell support for the treatment of AL (amyloid light-chain) amyloidosis: survival and responses in 25 patientsR L Comenzo, E Vosburgh, R H Falk, et al.
Pageof 10